Evidence map›Paper›PMID 22235204›Full record

ArticleJournal of oncology2012

Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System.

Anja Gulliksen, Helen Keegan, Cara Martin, John O'Leary, Lars A Solli, Inger Marie Falang, Petter Grønn, Aina Karlgård, Michal M Mielnik, Ib-Rune Johansen and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Molecular oncology testing in resource-limited settings.The Journal of molecular diagnostics : JMD · 2014
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 3 countries.

Anja GulliksenNorChip AS, Industriveien 8, 3490 Klokkarstua, Norway.
Helen Keegan
Cara Martin
John O'Leary
Lars A Solli
Inger Marie Falang
Petter Grønn
Aina Karlgård
Michal M Mielnik
Ib-Rune Johansen
Terje R Tofteberg
Tobias Baier
Rainer Gransee
Klaus Drese
Thomas Hansen-Hagge
Lutz Riegger
Peter Koltay
Roland Zengerle
Frank Karlsen
Dag Ausen
Liv Furuberg
NorChip (Norway) · NOSINTEF · NOBioFluidix (Germany) · DECarl Zeiss (Germany) · DEFraunhofer Institute for Microengineering and Microsystems · DETrinity College Dublin · IECoombe Women & Infants University Hospital · IEUniversity of Freiburg · DEUniversity of Oslo · NOVestfold University College · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The paper presents the development of a "proof-of-principle" hands-free and self-contained diagnostic platform for detection of human papillomavirus (HPV) E6/E7 mRNA in clinical specimens. The automated platform performs chip-based sample preconcentration, nucleic acid extraction, amplification, and real-time fluorescent detection with minimal user interfacing. It consists of two modular prototypes, one for sample preparation and one for amplification and detection; however, a common interface is available to facilitate later integration into one single module. Nucleic acid extracts (n = 28) from cervical cytology specimens extracted on the sample preparation chip were tested using the PreTect HPV-Proofer and achieved an overall detection rate for HPV across all dilutions of 50%-85.7%. A subset of 6 clinical samples extracted on the sample preparation chip module was chosen for complete validation on the NASBA chip module. For 4 of the samples, a 100% amplification for HPV 16 or 33 was obtained at the 1 : 10 dilution for microfluidic channels that filled correctly. The modules of a "sample-in, answer-out" diagnostic platform have been demonstrated from clinical sample input through sample preparation, amplification and final detection.

Identifiers

PMID22235204
PMCPMC3253481
OpenAlexW2027528736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.